The pharmacy benefit management sector just might be set for a VC-backed shakeup, says Rightway CEO and cofounder Jordan Feldman
In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO and cofounder Jordan Feldman says there’s an opportunity for disruption.
Tomas Kauer 
In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO and cofounder Jordan Feldman says there’s an opportunity for disruption. Read More
